📈

Danaher Corporation

DHRDividend Contender • 12yrs
Healthcare · Diagnostics & Research🇺🇸 United States
$230.50
Dividend Yield0.69%
Annual Dividend$1.59
Ex-Dividend DateSep 30, 2026
Market Cap$157.77B
95/ 100
Financial Health
Healthy
Well-covered payout (26%)Conservative leverage (D/E 0.5x)Revenue growing (6%)

Automated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.

At a glance

Danaher Corporation (DHR) operates in the Diagnostics & Research industry and is based in the United States. It pays a quarterly dividend of $1.59 a year, a yield of 0.69% at the current price of $230.50. Danaher has raised its dividend for 12 consecutive years, which makes it a Dividend Contender. Over the last five years the dividend has grown by an average of 14.9% a year. It paid out 26% of its earnings as dividends, leaving most of its profit in the business. 25 analysts cover it; their average 12-month price target of $244.14 is 5.9% above the current price.

Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.

Price History
Dividend payment dates
Analyst Consensus
Buy
Bullish sentiment
84% of 25 analysts bullish
12-Month Price Target
$244.14
+5.9% vs current price

About Danaher Corporation

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.

Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.

Key Metrics

Valuation

P/E Ratio
40.8
P/B Ratio
3.00
EV/EBITDA
22.6
Beta
0.80
vs S&P 500
52W High
$242.80
52W Low
$160.93

Profitability

Gross Margin
58.75%
Operating Margin
19.78%
Net Margin
15.95%
ROE
7.61%
Free Cash Flow
$4.33B

Financial Health

Debt / Equity
52.97
lower is safer
Current Ratio
1.65
>1 healthy
Quick Ratio
1.15
>1 healthy
Employees
58,000
HQ
Washington, DC, United States
Data: Yahoo Finance (yfinance)|Updated: Oct 24, 2026 11:38

Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.

Legal Disclaimer

This website is not a financial advisor, investment advisor, or financial services provider. We do not offer, recommend, or imply any investment advice of any kind. We do not receive compensation, commissions, or any other benefit from any company, fund, financial product, or third party featured on this site. No content on this website constitutes a recommendation or solicitation to buy, sell, or hold any security or financial instrument.

All financial analysis, ratios, and written commentary are provided for educational and informational purposes only. The Financial Analysis and Financial Investigation sections reflect automated computations applied to publicly available financial data — they do not represent the opinion of a licensed financial professional. Always conduct your own independent research and consult a qualified, regulated financial adviser before making any investment decision. Past performance of dividends, prices, or earnings is not a guarantee of future results.

Data Sources: Yahoo Finance via yfinance (real-time prices, dividend history, financial statements, analyst ratings and price targets) · S&P 500 Dividend Aristocrats Index (official constituent list) · Dividend Kings public records (companies with 50+ years of consecutive dividend increases) · SEC EDGAR company filings (10-K annual reports — primary source for all financial statement data). Data is fetched automatically each day and may be delayed up to 24 hours. All figures are in USD unless otherwise stated.